Back to breakthrough data: HealthVerity Marketplace for healthcare data
Recently, HealthVerity COO and co-founder Andrew Goldberg spoke at a timely webinar: Back to...
Topic
Marketplace (2)
Real-world evidence on cenobamate monotherapy in epilepsy
Why real-world data matters in epilepsy research Epilepsy affects millions of adults in the United...
The rise of conversational AI in healthcare using EHR data
AI agents are quickly becoming part of the clinical conversation. Since the release of large...
Measuring cost savings of virtual PT with HealthVerity Marketplace closed claims
Recently, Omada Health and HealthVerity announced a press release highlighting their collaboration...
GLP-1 trends 2025: real-world data, patient outcomes & future therapies
Few areas of medicine have captured public interest over the past two years quite like...
Disparities in OUD treatment: Buprenorphine vs. naltrexone
Understanding disparities in opioid use disorder (OUD) treatment Pharmaceutical companies committed...
Gilead uses HealthVerity data to find liver-protective treatment
Antiretroviral therapy (ART) has transformed outcomes for people living with HIV, especially those...
Who's missing out? The truth behind food allergy treatment approvals
Mapping food allergy care with omalizumab and real-world data IgE-mediated food allergies (FAs)...
J&J's real-world bladder cancer study started in HealthVerity Marketplace
High-risk NMIBC: Disease overview and treatment approach Johnson & Johnson quickly identified and...
The Marketplace model is winning: key insights from our webinar
The HealthVerity Marketplace webinar wrapped up with a clear message. The Marketplace model is not...